Rincy Thomas
Family · Pembroke Pines, FLNPI 1588381024
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 80 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 16.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $986, 7.6 times the $129 reported in 2023.
Across 80 payments — averaging $19.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$268
- Novo Nordisk$167
- Exact Sciences$154
- Abbott$131
- Pfizer$124
- Amgen$103
- plus $644 from 15 others
What the payments were for
- Food & beverage$1,592100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 15 | $268 |
| Novo Nordisk | 8 | $167 |
| Exact Sciences | 7 | $154 |
| Abbott | 7 | $131 |
| Pfizer | 6 | $124 |
| Amgen | 6 | $103 |
| AbbVie | 5 | $99 |
| Astellas Pharma US Inc | 3 | $83 |
| AstraZeneca | 4 | $81 |
| Insmed, Inc. | 4 | $76 |
| Bayer | 3 | $66 |
| Dexcom, Inc. | 2 | $35 |
| GSK | 2 | $31 |
| Gilead | 1 | $26 |
| Esperion Therapeutics, Inc. | 1 | $25 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $24 |
| Idorsia Pharmaceuticals US Inc | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Shield Therapeutics Inc | 1 | $19 |
| IBSA Pharma Inc. | 1 | $18 |
How this compares
$1,592 in reported general payments places this provider in the 75th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 21 | $398 |
| Methylprednisolone | 27 | $164 |
| Amlodipine Besylate | 11 | $109 |
| Azithromycin | 20 | $80 |
| Prednisone | 11 | $18 |
Paid to pharmacies, not to this prescriber.
Other family in Pembroke Pines
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
- Ronda CrewsJax Bch$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.